ALMS
Alumis Inc
NASDAQ: ALMS · HEALTHCARE · BIOTECHNOLOGY
$24.69
+7.86% today
Updated 2026-04-30
Market cap
$2.91B
P/E ratio
—
P/S ratio
121.06x
EPS (TTM)
$-2.86
Dividend yield
—
52W range
$3 – $31
Volume
1.5M
Alumis Inc (ALMS) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Operating cash flow | $-107.72M | $-129.97M | $-255.08M | $-369.52M |
| Capital expenditures | $2.41M | $4.50M | $1.73M | $653000.00 |
| Depreciation | — | — | — | — |
| Stock-based comp | $5.96M | $8.63M | $19.46M | $43.52M |
| Free cash flow | $-110.13M | $-134.47M | $-256.81M | $-370.18M |
| Investing cash flow | — | — | — | — |
| Financing cash flow | — | — | — | — |
| Dividends paid | — | — | — | — |
| Share repurchases | — | — | — | — |
| Debt repayment | — | — | — | — |
| Net change in cash | — | — | — | — |